国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲欧美妆和亚洲妆的区别| 99久久精品免费看国产| 人人妻人人添人人爽欧美一区| 色欲精品人妻AV一区二区三区| 亚洲欧美在线观看| 国产精久久一区二区三区| 18禁黄久久久AAA片| 亚洲精品久久久久久久蜜桃| 欧美色视频日本片免费| 久久夜色精品国产嚕嚕亚洲av | 国产CHINESE白嫩小受GV| 性XXXFREEXXXX国产| 東京热AV精品人妻一区二区三区| 亚洲性色精品一区二区在线| 日韩高清无码| 男女啪啪做爰高潮免费网站| 又粗又大又硬毛片免费看| 国产男男激情VIDEOSGAY| 国产又色又爽又刺激在线观看 | 光棍天堂手机2019版免费观看| 日韩gay小鲜肉啪啪18禁 | 久久午夜夜伦鲁鲁片无码免费| 欧美牲交a欧美牲交aⅴ久久| 思思久久精品在热线热| 亚洲一区二区三区无码国产| 国产做A爰片久久毛片A片软件 | 无码国产精品一区二区免费虚拟vr| 寂寞人妻瑜伽被教练日| 国产嫖妓一区二区三区av视频| 欧美最猛性XXXXXX| 国产性色强伦免费视频| 国产精品久久久久久搜索| 欧美精品久久久久久久自慰| 久久99精品国产麻豆婷婷| 久久精品亚洲中文字幕无码网站| 在线视频免费观看www动漫| 四虎精品免费永久免费视频| 久久精品欧美av无码四区| 亚洲精品中文字幕无码蜜桃| 一区二区三区好用的精华液| 久久无码人妻精品一区二区三区 |